Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Amarin Triglyceride-Lowering Drug in Phase 3 Trial

August 10, 2010 7:42 am | News | Comments

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial.


Vertex HCV Drug Could Shorten Treatment Time

August 10, 2010 7:37 am | News | Comments

Vertex Pharmaceuticals Inc. said that a study showed some patients who take its hepatitis C drug candidate telaprevir may be able to complete their treatment sooner.


Nanomachines Useful For Cancer Drug Delivery

August 10, 2010 7:05 am | News | Comments

Scientists from UCLA's California NanoSystems Institute and Korea's Yonsei University have developed an innovative method that enables nanomachines to release drugs inside living cancer cells when activated remotely by an oscillating magnetic field.


Teva Acquires Ratiopharm

August 10, 2010 7:00 am | News | Comments

Teva Pharmaceutical has solidified operations further in Europe, announcing that it completed a $4.95 billion buyout of German drugmaker Ratiopharm.


Most Doctors Prescribing Alzheimer's Drugs for MCI

August 10, 2010 6:57 am | by Lauran Neergaard | News | Comments

Doctors can't tell if Leif Utoft Bollesen's mild memory loss will remain an annoyance or worsen, but experimental checks of the Minnesota man's aging brain may offer clues.


WHO Declares Flu Pandemic Over

August 10, 2010 6:54 am | by Frank Jordans | News | Comments

The World Health Organization has declared the swine flu pandemic officially over, months after many national authorities started canceling vaccine orders and shutting down hot lines as the disease ebbed from the headlines.


Merck Under Investigation for Violating Anti-Bribery Laws

August 10, 2010 6:52 am | by Linda A. Johnson | News | Comments

Merck, the world's second-biggest drugmaker by revenue, has received inquiry letters from both the Department of Justice and the Securities and Exchange Commission seeking information about activities in a number of countries and reference the Foreign Corrupt Practices Act.


Measuring Multiple Indications

August 9, 2010 11:37 am | by Daniel G. Baker, MD, Vice President, Immunology, Centocor Research and Development, Inc., Chesterbrook, Pa. | Articles | Comments

A unique clinical development program speeds Phase 3 trials.


Analyzing High-Dimensional Data Sets Using Dynamic PCA

August 9, 2010 11:31 am | by Qlucore, Lund, Sweden | Articles | Comments

Qlucore Omics Explorer enables scientists to analyse very large data sets using combination of statistical methods and visualization techniques, without having to be a statistics or computer expert.


Translational Research Foundation Helps Dana-Farber Cancer Institute Accelerate Discovery

August 9, 2010 11:22 am | by Arvindh Balakrishnan, Vice President, Oracle Life Sciences Industry Business Unit | Articles | Comments

Scientists at the Dana-Farber Cancer Institute—one of the leading cancer research and care centers in the United States—have pioneered a new approach to manage the massive amount of data needed to accelerate medical research.


Target Reporter System

August 9, 2010 8:27 am | Drug Discovery & Development | Product Releases | Comments

Sigma Life Science and SwitchGear Genomics, Inc. announced a joint project to develop and distribute a novel microRNA target reporter system.


Cell Microarray

August 9, 2010 8:19 am | Product Releases | Comments

The DEPArray System is a cell microarray implementing patented technology for individual rare cell detection and recovery from suspensions.


AB Sciex Collaborating With CDC on Mass Spec

August 9, 2010 8:04 am | News | Comments

AB SCIEX, a global leader in life science analytical technologies, today announced a collaboration with the Centers for Disease Control and Prevention (CDC) and the CDC Foundation to facilitate the use of mass spectrometry technologies in clinical laboratories for hormone testing.


Horizon Receives EU Personalized Medicine Grant

August 9, 2010 8:00 am | News | Comments

Horizon Discovery announced that it is to be part of a new four year EUFP7 personalized medicine consortium. The PREDICT Consortium was established to coordinate single drug clinical trials and define patient-specific drug sensitivity pathways and biomarkers predictive of drug response.


Genetic Differences Confer Natural Immunity to Some

August 9, 2010 7:56 am | News | Comments

Genetic differences that make some people susceptible to developing meningococcal meningitis and septicaemia, and others naturally immune, are revealed in a new study of over 6,000 people.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.